453

Compound name
Fostamatinib
Alt Name
R788
Tavalisse
Compound Image
Fostamatinib.png
SMILES
CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C
MW
580.50
Brutto
C23H26FN6O9P
InChI
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)
InChI Key
GKDRMWXFWHEQQT-UHFFFAOYSA-N
Approval Jurisdiction
2018 FDA 2020 EMA
Approved for clinical use
Autoimmune Thrombocyto-Penia
CAS
901119-35-5
PubChem CID
11671467
Action
SYK
Approved Drug List
1
Commercial Vendor
Rigel Pharmaceuticals